1. The aminopenicillins: Development and comparative properties

   • D. S. Reeves
   • D. W. Bullock

   Introduction Pages: S425 - S433

2. Influence of aminopenicillins on bacterial growth kinetics in vitro in comparison with the antibacterial effect in vivo

   • H. Mattie
   • G. B. van der Voet

   Preclinical Evaluation Pages: S434 - S437

3. Comparative in vivo activity of bacampicillin and amoxycillin

   • B. Ekström
   • L. -P. Jalar
   • L. Magni

   Preclinical Evaluation Pages: S438 - S442

4. Efficacy of bacampicillin and ampicillin in experimental pyelonephritis in the rat

   • W. Ritzerfeld

   Preclinical Evaluation Pages: S443 - S445

5. Effect of bacampicillin on human mouth, throat and colon flora

   • A. Heimdahl
   • C. E. Nord
   • K. Weilander

   Preclinical Evaluation Pages: S446 - S451

6. Effects of subinhibitory amounts of ampicillin, amoxycillin and mecillinam on the adhesion of escherichia coli bacteria to human urinary tract epithelial cells: A preliminary study

   • C. Svanborg-Edén
   • T. Sandberg
   • S. Ahlstedt

   Preclinical Evaluation Pages: S452 - S455

7. Clinical pharmacological evaluation of aminopenicillins

   • H. Mattie
   • P. L. Meenhorst

   Clinical Pharmacological Evaluation Pages: S456 - S457

8. Dose dependence in human absorption of aminopenicillins

   • J. Sjövall

   Clinical Pharmacological Evaluation Pages: S458 - S462

9. Penetration of ampicillin into human bronchial secretions

   • E. Bergogne-Berezin
   • G. Berthelot
   • C. Morel

   Clinical Pharmacological Evaluation Pages: S463 - S464

10. Serum and sputum antibiotic levels after ampicillin, amoxycillin and bacampicillin in chronic bronchitis patients

    • B. Davies
    • F. Maesen

    Clinical Pharmacological Evaluation Pages: S465 - S468

11. Ampicillin concentration in normal and pathological lung tissues after oral administration of bacampicillin

    • O. Hällström
    • O. Keyriläinen
    • H. Markkula

    Clinical Pharmacological Evaluation Pages: S469 - S471

12. Ampicillin concentrations in middle ear effusions in acute otitis media after administration of bacampicillin

    • S. Virtanen
    • E. -A. Lahikainen

    Clinical Pharmacological Evaluation Pages: S472 - S474

13. A pharmacokinetic study of bacampicillin in patients with chronic maxillary sinusitis

    • M. Sorri
    • K. Jokinen
    • E. Peltomäki

    Clinical Pharmacological Evaluation Pages: S475 - S477

14. Penetration of ampicillin into urethral and cervical secretions after oral administration of bacampicillin

    • L. O. Kallings
    • G. Eriksson
    • U. -B. Linse

    Clinical Pharmacological Evaluation Pages: S478 - S482

15. A clinical comparison of ampicillin, ampicillin esters (bacampicillin and pivampicillin) and amoxycillin in acute exacerbations of chronic bronchitis

    • F. Maesen
    • B. Davies

    Clinical Evaluation Pages: S483 - S486

16. A dose response study with bacampicillin in uncomplicated gonorrhoea

    • J. Wallin
    • S. Bengtsson
    • G. Wallmark

    Clinical Evaluation Pages: S487 - S488

17. Bacampicillin and ampicillin in urinary tract infections: A double-blind comparison of efficacy and tolerance

    • K. H. Müller-Ehrenberg
    • G. Müller

    Clinical Evaluation Pages: S489 - S491

18. Elimination of bacteria during antibacterial chemotherapy — a neglected parameter of chemotherapy

    • E. B. Helm
    • I. Munk
    • W. Stille

    Clinical Evaluation Pages: S492 - S494

19. A double-blind comparison of the clinical tolerance of bacampicillin and pivampicillin

    • Å. Koldestam
    • S. Olsson
    • L. Berglund

    Clinical Evaluation Pages: S495 - S498

20. Experimental evidence of a decreased incidence of penicillin allergy through use of pure penicillins

    • S. Ahlstedt
    • A. Kristofferson

    Clinical Evaluation Pages: S499 - S502

21. Review of side-effects of aminopenicillins

    • F. Nordbring

    Clinical Evaluation Pages: S503 - S506

22. Aminopenicillins: Concluding remarks

    • T. Bergan

    Clinical Evaluation Pages: S507 - S512